KOKON Consultation on Complementary Medicine in Oncology - a Pilot Study
Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Aug 21, 2014
Trial Information
Current as of April 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria for physicians:
- • age \>18 years
- • working in a breast center of comprehensive cancer center
- • able to consult 10 patients within working hours
- • training group: able to participate in on-site-training
- • not primarily treating the patients that are consulted
- • good language skills (for consultations)
- • informed consent
- Inclusion Criteria for patients:
- • age \> 18 years
- • female
- • diagnosis of breast-cancer
- • patient in the participating center
- • good language skills (for consultations)
- • informed consent
Trial Officials
Claudia M Witt, MD, MBA
Principal Investigator
Charite University, Berlin, Germany
About Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin, , Germany
Berlin, , Germany
Berlin, , Germany
Berlin, , Germany
Heidelberg, , Germany
München, , Germany
Nürnberg, , Germany
Würzburg, , Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials